Stocks
Black Diamond Therapeutics (BDTX) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -29.3 | -66.7 | -126.7 | -92.3 | -86.0 | -78.4 | ||
| Changes by years, y/y, % | +230% | +128% | +90% | -27% | -7% | +57.5% | |||
Black Diamond Therapeutics. EBITDA US GAAP, bln rub
Black Diamond Therapeutics. EBITDA US GAAP, changes, %
Black Diamond Therapeutics. EBITDA US GAAP, sum by quarters, bln rub
Black Diamond Therapeutics (BDTX) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -24.0 | -20.8 | -20.2 | -22.0 | -15.5 | -78.4 | |
| Changes by years, y/y, % | +9% | -14% | -6% | +11% | -36% | |||
| Changes by quarters, q/q, % | +21% | -14% | -3% | +9% | -30% | |||
